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Abstract
The incidence of esophageal adenocarcinoma (EAC) is rising in the United States. An important risk factor for EAC is
the presence of Barrett esophagus (BE). BE is the replacement of normal squamous esophageal epithelium with a
specialized columnar epithelium in response to chronic acid and bile reflux. However, the emergence of BE from
squamous keratinocytes has not yet been demonstrated. Our research has focused on this. Wnt and cyclooxygenase 2
(Cox2) are two pathways whose activation has been associated with BE and progression to EAC, but their role has not
been tested experimentally. To explore their contribution, we engineered a human esophageal keratinocyte cell line to
express either a dominant-active Wnt effector CatCLef or a Cox2 complementary DNA. In a two-dimensional culture
environment, Cox2 expression increases cell proliferation and migration, but neither transgene induces known BE
markers. In contrast, when these cells were placed into three-dimensional organotypic culture conditions, we
observed more profound effects. CatCLef-expressing cells were more proliferative, developed a thicker epithelium,
and upregulated Notch signaling and several BE markers including NHE2. Cox2 expression also increased cell prolif-
eration and induced a thicker epithelium. More importantly, we observed cysts form within the epithelium, filled with
intestinal mucins including Muc5B and Muc17. This suggests that Cox2 expression in a three-dimensional culture
environment induces a lineage of mucin-secreting cells and supports an important causal role for Cox2 in BE patho-
genesis. We conclude that in vitro modeling of BE pathogenesis can be improved by enhancing Wnt signaling and
Cox2 activity and using three-dimensional organotypic culture conditions.
Neoplasia (2011) 13, 792–805
Introduction
Esophageal adenocarcinoma (EAC) is a leading cause of death in the
United States [1]. For the past 30 years, EAC incidence has risen at
an alarming rate, making it an increasingly important human cancer.
Typically, EAC does not arise in normal squamous esophageal mucosa
but usually is seen developing in an altered, premalignant mucosa
known as Barrett esophagus (BE) [2,3]. BE is characterized by the
replacement of normal, squamous epithelium with a metaplasia con-
sisting of columnar mucosa with a morphology and gene expression
pattern more typical of intestinal epithelium. Intestinal proteins like
villin, sucrase isomaltase, acidic mucins/MUC2, and the intestine-
specific transcription factor Cdx2 are commonly detected in BE [2].
Whereas Cdx2, as the master regulator of the intestinal cell phenotype
[4,5], undoubtedly plays an important role in the pathogenesis of BE,
its expression alone has not been sufficient to induce BE metaplasia
in esophageal keratinocytes [6–9]. Other developmental and signal-
ing pathways seem to be necessary to induce the emergence of an
intestinalized epithelium from keratinocyte precursors.
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The current paradigm for the induction of BE requires gastric acid
and bile reflux to induce tissue injury, resulting in the release of pro-
inflammatory cytokines and other inflammatory mediators including
eicosanoids like prostaglandin E2 (PGE2) [10–14]. PGE2 is the most
abundant prostanoid in BE. It stimulates angiogenesis, increases cell
proliferation and migration, and inhibits apoptosis [15–18]. Cyclo-
oxygenases (Cox1 and Cox2) are the rate-limiting enzymes in pros-
taglandin biosynthesis [19–21]. Cox2 expression is induced in the
esophagus by acid reflux, and its expression levels directly correlate with
the degree of acid reflux injury [14,22]. Moreover, Cox2 is a known
oncogene [23]. It is therefore hypothesized that Cox2 expression may
promote esophageal adenocarcinogenesis, as Cox2 levels are increased
in BE, and increase further with the onset of dysplasia and cancer [24–
26]. Despite the supportive clinical data, a role for Cox2 in the patho-
genesis of BE and EAC has not been formally tested.
The Wingless (Wnt) pathway is another signaling mechanism
thought to contribute to BE pathogenesis. In the intestine, Wnt signal-
ing, mediated by β-catenin intracellularly, is required for intestinal
secretory cell fates, cell proliferation, and stem cell maintenance [27–
29]. Moreover, it has been shown that active Wnt signaling during
development can induce intestinal gene expression and morphology
in lung endoderm, including the development of intestinal mucin-
secreting goblet cells [30]. Several clinical observations suggest that
activation of the Wnt signaling may contribute to the development of
BE. The progression of BE to adenocarcinoma was marked by loss
of several negative regulators of Wnt signaling as well and induction
of Wnt-2 expression [31–35]. These changes would be expected to
increase signaling along the Wnt axis. However, despite these findings,
little is known about howWnt signaling may promote intestinalization
and the onset of BE.
Using a novel human esophageal keratinocyte cell line immortalized
only by ectopic telomerase expression (EPC-hTERT, known here as
STR cells) [36,37], we previously determined that ectopic expression
of Cdx2, when combined with cyclin D1 overexpression and chroma-
tin remodeling drugs or with c-Myc expression, induces a more BE-like
gene expression pattern [6–8]. In the present study, we advance these
observations by exploring the effects of ectopic activation of Cox2 or
Wnt signaling on the STR cell function and differentiation in two-
dimensional and three-dimensional culture systems.
Materials and Methods
Cell Culture and Transfections
Immortalized human primary esophageal epithelial cells STR (EPC-
hTERT) were developed and maintained as previously described
[8,36,37]. Stable transduction of esophageal cells with retroviral vectors
has been described previously [6,8]. The polymerase chain reaction
(PCR) primers sequences are as the following: forward, 5′-GCGCCT-
CGAGGCTCCACAGCC AGACGCC-3′; reverse, 5′-GCCGGAAT-
TCCATTAGACTTCTACAGTTC-3′. The MSCV vector includes
an internal ribosomal entry site (IRES) and a 3′ neomycin resistance
complementary DNA (cDNA). The Cox2 cDNA was subcloned into
the multicloning site 5′ to the IRES. The inserted region of the con-
structs was verified by DNA sequencing. They were transfected into
a Phoenix-Ampho packaging cell line (a gift from Dr Garry Nolan,
Stanford University, Palo Alto, CA) with Lipofectamine 2000 reagent
(Invitrogen, Life Technologies, Carlsbad, CA) according to the manu-
facturer’s instructions.
Culture supernatants from individual Phoenix-Ampho cells were
purified as described elsewhere [38] and were used to infect STR
cells. Cells were passaged 48 hours after infection and selected with
300 μg/ml neomycin (Invitrogen) for 5 days. The CatCLef1 cDNA
fragment (kindly provided by Dr Brigid LM Hogan, Duke Univer-
sity, Durham, NC) was cloned into the lentiviral expression vector
pLEX-MCS (Open Biosystems Products, Huntsville, AL) and lentivirus
particles assembled in HEK293T. The PCR primer sequences are as
follows: forward, 5′-CGTTCTTTTCACTCTGGTGGA-3′; reverse,
5′-GTTAACCAAAGATGACTTGATG-3′. Lentiviral particles were
then used for polybrene-mediated transduction using standard protocols.
Cells were selected with 1 μg/ml puromycin (Invitrogen) for 7 days. The
MIGR1 and MIGR-Cdx2 retroviral vectors were described previously
[39–41]. Prostaglandin E2 was purchased from a commercial supplier
(14010; Cayman Chemical, Ann Arbor, MI).
Cell Proliferation and Migration Assays
Cell proliferation was quantified by colorimetry based on the meta-
bolic cleavage of the tetrazolium salt WST-1 in viable cells as recom-
mended by the manufacturer (Roche Applied Science, Mannheim,
Germany). As a second approach, bromodeoxyuridine (BrdU) incorpora-
tion was measured in Cox2- and CatCLef1-expressing and control cells.
Cells were incubated with BrdU (Zymed, Invitrogen Corp, Carlsbad,
CA) for 1 hour before fixation. BrdU staining was conducted via stan-
dard methods. 4′, 6-Diamidino-2-phenylindole (DAPI) (Sigma-Aldrich,
St Louis, MO) was used at a concentration of 1 μg/ml to highlight all
cells. Fluorescent samples were visualized and imaged using software
(IPLab; Scanalytics, Fairfax, VA). Cells stained for BrdU were scored
by counting five high-power fields.
Migration assays were carried out as described [40]. In brief, after cul-
turing cells without epidermal growth factor (EGF) for 48 hours, single-
cell suspensions containing 4 × 104 cells/well in 0.5 ml of K-SFM
(without EGF) were plated in triplicate into 24-well inserts (8 μm pore
size; Falcon Cell Culture Inserts; BD Bioscience, Bedford, MA). The
lower chamber was filled with 0.5 ml of K-SFM containing 0.5 μg/ml
hydrocortisone (Sigma) and 10 ng/ml EGF (BD Biosciences, Rockville,
MD).After incubating for 16 hours at 37°C, the cells on the upper side of
the Transwell membrane (BD Bioscience) were removed by cotton swab
and rinsed with phosphate-buffered saline. Cells migrating to the lower
side of membrane were fixed in 4% paraformaldehyde for 20 minutes
at room temperature, stained with crystal violet (Sigma), and counted.
Means and SDs were calculated and compared using Student’s t test.
PGE2 ELISA
Supernatant culture media were collected from overnight cultures of
1 × 104 cells in 96-well plates. Fifty microliters of culture supernatant
was used per sample. All samples were run in duplicate. PGE2 levels
in supernatants from STR.M.COX2 and control cells were quantified
with enzyme immunoassay (EIA) system PGE2 assay kit (R&D Sys-
tems, Inc, Minneapolis, MN) following the manufacturer’s protocol.
TOPf lash Luciferase Assay
The EPC2-hTERT cells were transfected using Lipofectamine LTX
reagent (Invitrogen). Cells were grown to 50% to 70% confluence and
were transfected with 100 ng of pRC expression vectors, 100 ng of
TOPflash (kindly provided by Dr Ken Kinzler, The Johns Hopkins
University), 200 ng of CatCLef1, 1 ng of pRL-CMV Renilla control
reporter (Promega, Madison, WI), and 700 μg of pCR2.1 (Stratagene,
La Jolla, CA) as carrier. Expression plasmids for pCGCatCLef1 and
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Plex-MCS-CatCLef1were described previously [30].Mediawere changed
at 24 hours, and at 48 hours, the cells were harvested. Luciferase assays
were performed using the dual-luciferase assay kit (Promega). Luciferase
activity was normalized to both total protein concentration and the
transfection control Renilla luciferase levels. Statistical testing was by
Student’s t test.
RNA Isolation and Real-time Quantitative PCR Analysis
Total RNA was isolated from Neo- or Puro-selected and control
cells using the RNAeasy kit (Qiagen, Germantown, MD). Five micro-
grams of total RNA was used for cDNA synthesis using the First-Strand
cDNA synthesis Kit (Invitrogen). Reverse transcription (RT)–negative
controls were included. Primer sequences for PCR are available in
Table W1. For the RT-PCR, cDNA and primers were mixed with
SYBR Green RT-PCRMaster Mix (Applied Biosystems, Life Technol-
ogies Corp, Carlsbad, CA) and then assayed in an ABI Prism 7000 se-
quence detection system as directed by the manufacturer. A ribosomal
phosphoprotein, 36B4, was used as the normalization control. Fold
change in RNA levels was calculated from the C t values using the
formula previously described [39,42]. The ΔΔC t values for each gene
were averaged across the RNA pools, SDs were calculated, and statistical
comparisons were performed using analysis of variance and Tukey rank
mean testing. These values were then converted to fold change to graphi-
cally report the findings.
Quantitative RT-PCR–Based TaqMan Low-Density Arrays
TaqMan Array 96-well fast plate (custom format 48; Applied Bio-
systems) included 45 specific genes and 3 housekeeping genes as inter-
nal controls. Total cellular RNA (2.5 μg) was reverse-transcribed using
SuperScript VILO cDNA Synthesis Kit (Invitrogen). cDNA, 1.25 ng,
was obtained for real-time PCR using ABI StepOnePlus Real-Time
PCR System (Applied Biosystems). The comparative C t method was
applied for quantification. The amount of messenger RNA (mRNA)
of a specific gene was measured by its threshold cycle (C t) and nor-
malized to that of 36B4, GAPDH, and 18S as n-fold difference (C t),
respectively. The expression of genes of interest in each sample was
then compared with the amount of a calibrator sample—that is, the
expression in the corresponding empty vector control (C t). Customized
96-well low-density arrays for PCR amplification were designed using
individual primers for genes of interest, chosen and purchased from
the assays on demand gene expression products (Applied Biosystems)
listed in Table W1. The probes were labeled with 5′-FAM and 3′-
minor groove binder/nonfluorescent quencher. To control for the
specificity of the assay, genomic DNA and total cellular RNA extracted
from biopsies were also tested. Master Mix (20 μl) containing cDNA
was loaded into each well. Each low-density array containing the genes
of interest was loaded with cDNA from STR-MSCV-Cox2, STR-Plex-
MCS-CatCLef1, and corresponding control sample for quantification
of mRNA expression of all the selected genes in one experiment by the
same array.
Organotypic Three-dimensional Culture
Organotypic culture was performed as previously described [6].
In brief, 0.5 × 106 of STR.M.COX2, STR.L.CatCLef, or their
corresponding controls were seeded on top of the collagen/Matrigel
matrices containing FEF3 human fetal esophageal fibroblasts and
grown in submerged conditions for 4 days. Cultures were then raised
to the air-liquid interface for an additional 4 days and harvested. The
cultures were split, with half fixed and embedded for histochemical
studies and the remainder processed for RNA extraction. Each organo-
typic culture experiment was performed in triplicate.
Protein Extraction and Western Blot Analysis
Whole cell extract was prepared as described [43]. Protein concen-
tration of samples and bovine serum albumin standard was determined
using the bicinchoninic acid protein assay kit (Pierce Biotechnology,
Rockford, IL). The blotted membranes were blocked with phosphate-
buffered saline with 0.2% Tween containing 5% skim milk, followed
by overnight incubation with the primary antisera or monoclonal anti-
bodies including mouse anti–COX-2 (SC-1745, 1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA), mouse anti-LEF1 antibody (1:1000;
Millipore Chemicon, Billerica, MA), anti–cyclin D1 (p16; Santa Cruz
Biotechnology), mouse antitubulin (1:2000; Sigma), and antiactin
(1:2000; Sigma) at 4°C. The secondary antibodies used were all from
Sigma-Aldrich and used at 1:3000. Targeted proteins were visualized
using an enhanced chemiluminescence detection system (ECL Plus;
GE Healthcare Bio-Sciences Corp, Piscataway, NJ) and exposed to Blue
Lite Autorad film (ISC-BioExpress, Kaysville, UT).
Alcian Blue Staining and Immunostaining
Harvested organotypic cultures were fixed in 1.5% paraformal-
dehyde and embedded in paraffin. For histology and immunohisto-
chemistry, 5- to 11-μm-thick sections were cut from the paraffin blocks
and stained with hematoxylin and eosin or Alcian blue by standard pro-
cedures. Immunohistochemical staining was performed with standard
techniques. Primary antibodies used include BrdU antibody (1:2500;
Upstate, Charlottesville, VA), chicken anti-NHE2 (1:500; Chemicon),
rabbit anti-Muc5B (1:50; Sigma-Aldrich), rabbit anti-Muc17 (1:20;
Sigma-Aldrich), rabbit anti-Filaggrin (1:1500, no. 24584; Abcam,
Cambridge, MA), rat anti-Notch1 (1:10; gift from Dr Spyros Artavanis-
Tsakonas, Harvard Medical School, Boston, MA), and Ki67 (1:3000,
VP-RM04; Vector Laboratories, Burlingame, CA). Sections were incu-
bated with primary and biotinylated secondary antibodies and an
avidin–horseradish peroxidase conjugate (Vectastain Elite ABC Kit;
Vector Laboratories) following the manufacturer’s protocol. The signal
was developed using the 3,3-diaminobenzidine substrate kit (Vector
Laboratories). Sections were counterstained with hematoxylin. Images
were obtained at 40× using a Leica microscope (Leica Microsystems, Inc,
Buffalo Grove, IL) with the Retiga 2000R digital camera (QImaging,
Surrey, British Columbia, United Kingdom) and the IP Lab imaging
software application (BD Biosciences). Exposure times were kept con-
stant for all samples. Muc5B antibody and Cy3-labeled antirabbit sec-
ondary antibody were used for immunof luorescence. For Alcian blue
staining, slides were deparaffinized. After application of 3% aqueous
acetic acid to the slides, 1% Alcian blue in 3% acetic acid, pH 2.5,
was applied. Sections were washed and counterstained with 0.1% nuclear
fast red, dehydrated, and mounted.
Results
Expression of a Protein Chimera Containing LEF1 and
the β-Catenin C-terminus Activates Wnt Signaling in
Human Keratinocytes
To provoke a direct, unopposed Wnt signal in our human keratino-
cyte cell line, we obtained a dominant active chimera in which an
amino-terminally truncated β-catenin is fused to a full-length LEF1
(Figure 1A). The chimera is called CatCLef1 (kindly provided by
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Dr Brigid Hogan, Duke University) [44]. This chimera induces in-
testinalization when ectopically expressed in lung endoderm during
embryogenesis [30]. We subcloned this chimera into a lentiviral vector
with a puromycin-selectable marker, generated infectious lentiviral
particles for the CatCLef1 and control vectors, and infected STR cells
with the viral supernatant. As a control for these studies, STR cells also
were infected with the original lentivirus that lacked the CatCLef
cDNA, we will refer to as the empty-cassette control. STR cells have
a normal cell morphology, wild-type p53, and form morphologically
normal-appearing squamous epithelium when cultured using three-
dimensional techniques [36,37].
We generated two distinct cell lines (STR.L.CatCLef#1 and STR.
L.CatCLef#2) and a control cell line (STR.L) and can demonstrate a
significant increase in CatCLef mRNA and protein levels by quan-
titative PCR and Western blot analysis in both when compared with
STR.L control cells (Figure 1, B and C ). CatCLef expression did not
seem to alter β-catenin protein levels (Figure 1D) but did increase
transcriptional activity from a canonical Wnt reporter TOPflash by
12-fold (Figure 1E). We have therefore established human esophageal
keratinocyte cell lines with ectopic β-catenin/T-cell factor transcrip-
tional activity.
Development of Human Esophageal Keratinocytes with
Ectopic Cox2 Expression
We subcloned a Cox2 cDNA into an MSCV-based retroviral vector
to drive expression of Cox2 in human esophageal keratinocytes. This
vector has a neomycin resistance cDNA downstream from an IRES as
the selectable marker (Figure 2A). Thus, cells resistant to neomycin
selection should also express Cox2. We generated active retroviral par-
ticles using this vector and subsequently infected the human esophageal
keratinocyte STR cells as before. After selecting for neomycin resis-
tance, we demonstrated Cox2 expression and normal enzyme function
in the STR-Cox2 cells. Cox2 mRNA was increased 100-fold over con-
trols that received no virus or the control MSCV-neo virus with an
empty cassette upstream of the IRES (Figure 2B). As before, we isolated
two distinct Cox2-expressing cell lines and a single control cell line
after separate infections and puromycin selections and can demonstrate
abundant Cox2 protein by Western blot analysis in the STR.M.Cox2
cells but not the control STR.M cells (Figure 2C ). Moreover, Cox2
expression was associated with significantly increased production of
prostaglandin PGE2 detected in the cell culture media of STR-Cox2
cells compared with control infected cells (Figure 2D). PGE2 levels
are increased by 20% at 24 hours after plating cells and by 60% at
Figure 1. Development of a human esophageal keratinocyte cell line with enhancedWnt/β-catenin signaling. (A) Map of β-catenin, Lef1, and
the CatCLef chimeric construct, as well as the lentiviral vector into which CatCLef is subcloned. (B) Fold change in CatCLef mRNA levels
after Lenti-CatCLef infection and selection (STR.L.CatCLef), compared with control lentivirus–infected cells (STR.L), n = 3. (C) Western
blot analysis for CatCLef protein levels in control (STR.L) and CatCLef-expressing cell lines (STR.L.CatCLef#1 and #2). (D) Western blot
analysis for endogenous β-catenin protein levels after CatCLef expression. (E) Wnt/β-catenin transcriptional activity on a canonical Wnt
reporter construct TOPflash in CatCLef-expressing (STR.L.CatCLef) and control cells (STR.L), n = 3.
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48 hours. These findings confirm ectopic Cox2 expression in STR
keratinocytes is associated with increased eicosanoid PGE2 biosynthesis.
Enhanced Wnt Signaling or Cox2 Activity Increased Cell
Proliferation and Migration in Cox2 Expressing Cells Only
Despite the significant induction of effective “Wnt” signaling by
the chimeric CatCLef, as evidenced by the increased luciferase activity
from the TOPflash reporter, there was no effect on keratinocyte pro-
liferation, as determined either by WST-1 assays (Roche Applied
Science), or BrdU incorporation (Figure 3, A and B). In contrast,
Cox2 expression was associated with a robust increase in cell prolifera-
tion (Figure 3, C and D). In a previous study, we demonstrated that
the expression of the intestine-specific transcription factor Cdx2 was
maintained in human STR cells only if cell proliferation was enhanced
by ectopic cyclin D1 expression [8]. Whereas both CatCLef and Cox2
expression did modestly increase cyclin D1 protein levels, neither
reached the levels achieved in the STR.D1 cells (Figure 3E) and they
were not enough to sustain Cdx2 expression in STR keratinocytes (data
not shown).
Wnt signaling and Cox2 activity have both previously been asso-
ciated with increased cell migration [21,45]. We therefore tested the
cell migratory activity of our STR.L.CatCLef and STR.M.Cox2 cells
using Boyden chambers. Cells were plated in the upper chamber,
and growth media were placed in the lower chamber. The number
of cells that passed through the 8.0-μm pores was determined at
24 hours. Whereas CatCLef-expressing cells had no significant change
in cell migration activity when compared with controls, the Cox2-
expressing cells had a seven-fold increase in cell migration (Figure 4).
In summary, Cox2 expression, but not CatCLef, was associated with
significantly enhanced cell proliferation and migration in human
STR keratinocytes.
CatCLef and Cox2 Expressing Cells Cultured under
Three-dimensional Organotypic Conditions Demonstrate
Altered Cell Proliferation and Morphology
We examined the STR.L.CatCLef and STR.M.Cox2 cells for
changes in cell morphology but observed none (data not shown). We
next examined for changes in mRNA levels for a small panel of
genes associated with intestinal epithelium and BE, including Alkaline
Phosphatase, NHE2, Muc2, Villin, and Keratin20, but there were no
significant differences observed between expressing and control cells
(data not shown). However, in a previous study, we noted that STR
cells expressing Barrett associated genes Cdx1 and cMyc demonstrated
significant intestinalization, including the production of Muc5AC,
only when cultured under three-dimensional organotypic conditions
that provokes STR cell differentiation [6]. We therefore cultured our
STR.L.CatCLef and STR.M.Cox2 cells similarly to determine whether
CatCLef or Cox2 expression could alter STR cell differentiation.
Figure 2. Establishing active Cox2 expression in human esophageal keratinocytes. Human STR keratinocytes were infected with a retro-
viral vector to induce Cox2 expression (MSCV-Cox2) or the control empty viral vector MSCV-Neo. Neomycin resistance serves as a
marker for viral infection and gene expression. (A) Map of MSCV-Cox2 retroviral construct. (B) Fold change in Cox2 mRNA levels after
MSCV-Cox2 infection and selection (STR.M.Cox2), compared with control MSCV virus–infected cells (STR.M), n = 3. (C) Western blot
analysis for Cox2 protein levels in control (STR.M) and Cox2-expressing cell lines (STR.M.Cox2#1 and #1). (D) PGE2 levels in the cell
culture media of control STR.M cells (white bar) and Cox2-expressing cells (gray bar) at 24 and 48 hours, n = 4.
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One finding that was immediately apparent was that the stratified
epithelium that developed from the STR.L.CatCLef cells was notice-
ably thicker than the control STR.L cells (Figure 5, A and B), nearly
double the thickness, on average (Figure 5C). Moreover, the basal cell
layer contained more cells and appeared crowded and more disorga-
nized than is observed in the control STR.L cells. Staining for Ki67+
cells demonstrated a two-fold increase in cell proliferation in the STR.
L.CatCLef organotypic epithelium when compared with controls.
Likewise, the STR.M.Cox2 cells also yielded a thicker epithelial layer
and increased Ki67+ cells compared with control STR.M cells when
both are cultured under organotypic conditions (Figure 6). These
differences were statistically significant and were in excess of two-fold
greater than controls. Moreover, they exceeded levels seen in the STR.
L.CatCLef cells, although this difference was not statistically significant.
Together, these findings support the conclusion that excess WNT sig-
naling in the form of CatCLef expression or Cox2 activity enhances
human keratinocyte STR cell proliferation and tissue thickness when
the cells are cultured under organotypic conditions.
The STR Keratinocyte Differentiation Program Is Altered by
CatCLef or Cox2 Expression
We next evaluated the organotypic cultures for evidence of altered
cell differentiation and the promotion of a more intestinalized epithe-
lium morphologically or by gene expression patterns. Alcian blue is
frequently used to identify the production of intestinal mucins and
goblet cells in Barrett epithelial biopsies. Staining of the CatCLef or
control STR.L cultures did not find a significant production of intes-
tinal mucins (Figure 7, A, B, or C). However, Cox2 expression did give
rise to cells producing and secreting intestinal mucins, whereas the
control culture did not (Figure 7, D, E , and F). Small pools of Alcian
blue–positive, acellular material are observed in cultures derived from
both STR.M.Cox2 cell lines. These Alcian blue–positive pools resemble
Figure 3. Increased cell proliferation was observed with Cox2 expression but not CatCLef. (A) WST-1 cell accumulation studies (Roche)
performed on STR (solid line) parental cells as well as STR.L (short dash line) and STR.L.CatCLef cells (long dash line), n = 8, each time
point. (B) BrdU incorporation assay performed on performed on STR, STR.L, and STR.L.CatCLef cells, n= 3. (C) WST-1 cell accumulation
study of STR.M (solid black line) and STR.M.Cox2 cells (solid gray line), n = 8. (D) BrdU incorporation assay for STR.M and STR.M.Cox2
cells, n = 3. (E) Western blot analysis for cyclin D1 protein levels in STR cells overexpressing cyclin D1, cyclin D1 and Cdx2, CatCLef,
Cox2, and control cells. Tubulin served as loading control.
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mucinous cysts, with a border of cells surrounding them. There are no
visible goblet-like cells in any of the sections studied. However, a closer
examination of sections stained for other markers revealed a well-defined
cyst with polarized, columnar cells in one section stained for Ki67
(Figure 7G). Of note, associated with this cystic structure, there are pro-
liferating Ki67+ cells. These proliferating cells, which seem to be contrib-
uting cells to the cyst, are out of their usual position, which should be
along the basal layer of the epithelium. Together, these findings suggest
that Cox2 expression in human esophageal keratinocytes can elicit mor-
phologic alterations and intestinal mucin production in a subset of cells.
To explore this response further, we screened mRNA expression
levels for a custom panel of 45 genes using a quantitative PCR array
Figure 4. Cox2 expression but not CatCLef increases STR human keratinocyte cell migration in Boyden chamber assays. Cell migration
was evaluated in Boyden chambers for STR.L.CatCLef and STR.M.Cox2 cells compared with control STR.L and STR.M, respectively.
(A) Example view of filter from each evaluated cell line. (B) Quantitation of cell counts from filters; three fields/filter were evaluated.
Experiment was performed in triplicate, n = 9.
Figure 5. CatCLef increases epithelial thickness and cell proliferation when cells cultured under organotypic conditions. Hematoxylin and
eosin stain of epithelial tissues sections from STR.L control (A) and STR.L.CatCLef cells (B) after cultured under organotypic conditions.
(C) Quantification of epithelial thickness, measured in three regions from three different tissue sections per culture, n = 9. (D and E)
Ki67 staining in tissue sections from STR.L (D) and STR.L.CatCLef cells (E). (F) Quantitation of Ki67-positive staining. The number of Ki67+
cells was expressed as a percentage of the total number of basal keratinocytes in a counted field, n = 6.
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(Applied Biosystems), planning to carefully validate any gene found
different in the screening study. The genes were selected as markers
associated with keratinocyte differentiation, BE, or intestinal epithelial
cells and included a number of keratins as well as mucins. Total
RNA isolated from the epithelium of the organotypic cultures of
STR.L.CatCLef and STR.M.Cox2 cells, and their control STR.L
and STR.M cells, were subjected to this quantitative PCR array screen.
We found from this screen that 19 genes in the STR.L.CatCLef
were different by two-fold or more when compared with the control
STR.L cells similarly cultured (Table W2). Many of the differences
were with keratins, which were largely induced. Some of these keratins
are associated with multilayered squamous epithelium (K4, K13, K15)
and others expressed more typically with simple epithelia (K10
and K19) [46]. Comparing STR.M and STR.M.Cox2 cells identified
21 genes that were two-fold or greater different between the cell lines
(TableW3). Four of the eight genes induced were mucins, supporting the
Alcian blue staining results, and two were keratins 7 and 19, associated
with simple epithelium. Moreover, we observed reductions in mRNA
levels of stratified squamous epithelial factors including keratins 1, 4, 5,
13, and 14, Filaggrin, and Loricrin. Together, these findings suggest that
the ectopic expression of CatCLef or Cox2, in conjunction with culture
under differentiation-producing organotypic conditions, can induce sig-
nificant alterations in the normal keratinocyte differentiation patterns.
CatCLef Expression Increases Notch Signaling and Alters
Keratinocyte Differentiation
Wenext performed validation studies on selected genes from the screen-
ing studies. We noticed the induction of two Notch pathway factors,
Notch1 and Hes1, in our screening PCR array for STR.L.CatCLef cells.
Given the association of Notch signaling with esophageal squamous cell
differentiation [47] and the requirement of Notch and β-catenin for cell
proliferation in the intestine [48], we selected these as two mRNA prod-
ucts for additional validation. As expected, when control cells are cul-
tured under organotypic conditions, levels of these two mRNA species
are increased two- to three-fold, whereas in cells expressing CatCLef,
a significant five- to seven-fold increase was observed (Figure 8, A and
B). Notch1 protein expression in normal human esophagus localizes to
the lower layers of the epithelium but is not exclusive to the basal cell
layer (Figure 8C). In our organotypic cultures, we see this pattern reca-
pitulated; however, CatCLef tissues express a considerably greater level of
Notch1 protein, supporting the quantitative PCR findings (Figure 8D).
Similarly, we noted an increased expression of NHE2mRNA, a marker
we previously identified as increased in BE [8], and reductions in Filaggrin
mRNA levels, a keratin-binding protein expressed in terminally differ-
entiated keratinocytes [49] in CatCLef-expressing cells, but only under
organotypic culture conditions. NHE2mRNA levels are increased 70-fold,
and cytoplasmic staining for NHE2 localizes to the basal and suprabasal
layers and compares well with staining patterns in normal human colon
(Figure 8, E and F ; data not shown). In contrast, there was a significant
reduction in Filaggrin protein levels (Figure 8G), suggesting CatCLef
expression interfered with keratinocyte terminal differentiation. In sum-
mary, ectopic Wnt signaling mediated by CatCLef enhanced Notch
signaling and induced a more intestinalized gene expression pattern in
human esophageal keratinocytes cultured under organotypic conditions.
Cox2 Expression Induces the Expression of Intestinal Mucins
in Human Esophageal Keratinocytes
Given the findings of mucin-filled cystic structures in the organo-
typic STR.M.Cox2 cultures, we next verified the enhanced expression
of some of the mucins observed in our PCR array screen. Muc1,
Figure 6. Cox2 expression increases epithelial thickness and cell proliferation of STR cells grown under organotypic conditions as in
Figure 5. Hematoxylin and eosin stain of epithelial tissues sections from STR.M control (A) and STR.M.Cox2 cells (B) cultured under
organotypic conditions. (C) Quantification of epithelial thickness measured as before, n = 9. (D and E) Ki67 staining in tissue sections
from STR.M (D) and STR.M.Cox2 cells (E). (F) Quantitation of Ki67-positive staining determined as before, n = 6.
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although strongly induced, is normally expressed in keratinocytes and
was therefore less interesting. The three remaining mucins are all
normally expressed in intestinal epithelium and were therefore of inter-
est [50]. Muc5B is a secreted gel-forming mucin previously reported in
esophageal submucosal gland cells but not BE [51]. We determined
that its expression was significantly induced 400-fold over control
cells cultured under two-dimensional conditions and 75-fold over
organotypic-cultured control STR.M cells (Figure 9A). This could be
confirmed immunohistochemically, with the control STR.M cells not
staining for Muc5B but the mucin-filled cystic structures strongly posi-
tive for Muc5B in the organotypic STR.M.Cox2 cultures (Figure 9,
B and C). Staining with this antibody is highly specific for colonic gob-
let cells (Figure 9D). Moreover, using this antibody, we were able to
detect Muc5B histologically in human Barrett specimens (Figure 9E).
We further extended this work by examining the expression of
Muc17 and Filaggrin in the organotypically cultured STR.M.Cox2
cells. Muc17 is a membrane-bound mucin thought to be expressed
exclusively in the intestine [50]. We found levels of Muc17 mRNA
were increased 90-fold over control cultured cells, including 18-fold
over organotypically cultured STR.M control cells (Figure 10A). This
was supported by immunohistochemical studies demonstrating Muc17
expression specifically in the mucin-cystic structures of the STR.M.
Cox2 cells but not control STR.M cells (Figure 10B). Lastly, Cox2
expression reduced keratinocyte differentiation, as evidenced by the
significant reduction in Filaggrin protein levels (Figure 10C). In sum-
mary, Cox2 expression in human keratinocytes promoted the expression
and secretion of intestinal mucins when the cells were cultured under
organotypic conditions that promote cell differentiation.
Figure 7. Cox2 expression induces intestinal mucin secretion in a subset of STR cells grown under organotypic conditions. Sections
from the organotypic cultures of established cell lines expressing CatCLef, Cox2, or their controls were stained with Alcian blue to
identify intestinal mucins. (A) STR.L control cells in culture. (B) STR.L.CatCLef cell line #1. (C) STR.L.CatCLef cell line #2. (D) STR.M
control cells in culture. (E) STR.M.Cox2 cell line #1. (F) STR.M.Cox2 cell line #2. (G) Cystic structure noted in section from STR.M.Cox2
cells stained for Ki67. Note the cells with a polarized morphology along the cyst border (black arrow) and the proliferating Ki67+ cells
(brown nuclei, black arrowhead) that have migrated above the basal cell layer.
800 Cox2 and Wnt Intestinalize Esophageal STR Cells Kong et al. Neoplasia Vol. 13, No. 9, 2011
Discussion
BE is an important clinical condition that increases one’s risk for
developing EAC. One critical limitation in our understanding of
the pathogenesis for BE has been the dearth of research models. It
has hampered our ability to identify the BE progenitor cell, test
hypotheses regarding causation, evaluate preventative and therapeutic
strategies, and determine which genes and signaling pathways are
critical for BE development. This study was initiated to extend earlier
work by us seeking to model BE pathogenesis in an in vitro cell cul-
ture system [6,8]. In these studies, we observed that ectopic Cdx1
or Cdx2 expression could promote a more intestinalized pattern
of gene expression in human esophageal STR keratinocyte. How-
ever, in both studies, it was determined that ectopic expression of
these factors alone would not be enough to induce Barrett epithelial
cells from the human keratinocytes; other agents or gene products
would be needed. In the present study, we identified two likely co-
factors in the pathogenesis of BE: enhanced Wnt signaling and Cox2
enzymatic activity.
Figure 8. CatCLef expression enhances Notch signaling and alters STR cell differentiation. (A and B) Quantitative SYBR Green RT-PCR
analysis of Hes1 (A) and Notch1 (B) mRNA expression in STR.L or STR.L.CatCLef cells cultured under normal two-dimensional conditions
or under three-dimensional organotypic conditions (OTSTR.L and OTSTR.L.CatCLef). ΔC t values were calculated after duplicate PCRs for
each sample and statistical analysis was performed (analysis of variance and Tukey rankmean). ΔΔC t values were then calculated and used
to determine fold change in expression. n = 4. aSignificantly differs from STR.L cells, P < .05. bSignificantly differs from STR.L.CatCLef
cells, P < .05. (C) Immunohistochemistry for Notch1 in normal human esophagus. (D) Notch1 immunohistochemistry in organotypic cul-
tures of STR.L and STR.L.CatCLef cells. (E) Quantitative SYBRGreen RT-PCR for NHE2mRNA levels in STR.L or STR.L.CatCLef cells cultured
under normal two-dimensional conditions or under three-dimensional organotypic conditions, n = 4. (F) NHE2 immunohistochemistry in
organotypic cultures of STR.L and STR.L.CatCLef cells. (G) Filaggrin staining in organotypic cultures of STR.L and STR.L.CatCLef cells.
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Increased Wnt Activity Significantly Alters Human
Keratinocyte Proliferation and Differentiation When
Cultured under Organotypic Conditions
The importance of Wnt signaling for proliferation and differentia-
tion of the normal intestinal epithelium cannot be overstated [52].
This argues for a similarly important role for Wnt in the pathogenesis
of BE. Although there are some data in support of this hypothesis
[31–35], more work needs to be done to clarify the role for Wnt
in this disease process. Our findings here do support this hypothesis
because enhanced Wnt signaling (mediated by the chimeric protein
CatCLef ) did increase the expression of keratins associated with
simple epithelium, as well as NHE2, an exchange protein highly
expressed in intestinal epithelium and BE.
In addition, we unexpectedly found that Notch signaling was
also increased with Wnt signaling. Notch and Wnt/β-catenin are
well-known collaborators in the intestine, where, together, they sup-
port intestinal stem cell maintenance and normal epithelial cell
proliferation as well as drive cell proliferation in colon neoplasias
[48]. It is interesting to speculate that the observed increase in cell
proliferation noted in the three-dimensional culture system is due to
Figure 9. Intestinal and subepithelial gland mucin Muc5B induced by Cox2 expression in STR cells. (A) Quantitative SYBR Green RT-PCR
analysis of Muc5B mRNA expression in STR.M or STR.M.Cox2 cells cultured under normal two-dimensional conditions or under three-
dimensional organotypic conditions (OTSTR.M and OTSTR.M.Cox2). ΔC t values and statistical analysis were calculated as before after
duplicate PCRs for each sample, n = 4. *Significantly differs from all other cells, P < .01. NS indicates nonsignificant difference with
STR.M or STR.M.Cox2. (B) Negative immunohistochemical staining for Muc5B in STR.M control cells in organotypic cultures. (C) Muc5B
immunohistochemical staining localized to the mucin-containing cysts in organotypic cultures of both STR.M.Cox2 cell lines (#1 and
#2). (D) Pattern for Muc5B expression in normal human colon by immunohistochemical staining. (E) Epifluorescent staining for Muc5B
(red) in human Barrett epithelium biopsy section. Nuclei counterstained with DAPI (blue). Shown on the right is a merged image of the
fluorescent channels with a differential interference contrast image of the tissue.
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an interaction between Wnt and Notch that does not occur in the
two-dimensional system because the cells are maintained in sparse,
noncontacting conditions to prevent differentiation. Moreover, the
observed diminished keratinocyte differentiation associated with in-
creased Notch activity (failed expression of Filaggrin) runs contrary
to a recently published study demonstrating a role for Notch in
keratinocyte differentiation [47]. It is not clear whether this failure
is due to the Notch signaling being too high or if it is an effect of
the Wnt pathway in conjunction with Notch. The elevated Notch
levels also may be the reason we failed to see induction of intestinal
secretory gene products because, in the intestine, Notch is known to
prevent goblet cell development [48]. These remain open questions
and important areas for future investigation.
Cox2 Expression Can Induce a Cell Morphology and Gene
Expression Shift in Human Esophageal Keratinocytes
The fact that Cox2 expression yielded highly significant findings
in this study are in some respects not surprising. It is consistent with
clinical studies of BE pathogenesis, in which Cox2 expression is
induced in the esophagus by acid reflux and further increased in BE
and EAC [24–26]. Moreover, Cox2 inhibition in a rat surgical model
of Barrett and EAC decreased tumor formation [53]. Despite these
supportive data, a role for Cox2 in the pathogenesis of BE and EAC
has not been formally tested until our studies reported here.
The induction of intestinal mucin-containing cysts within the de-
veloping multilayered epithelium of STR.M.Cox2 cells is an important
finding. It suggests that the mucin secretion is polarized to collect in the
discreet cysts, and it therefore establishes in principle that polarized
mucin-secreting cells can emerge from the squamous cells and therefore
suggests the possibility that the Barrett specialized columnar epithelial
cells likewise can be derived from a keratinocyte precursor. It is important
to note that not all cells expressing Cox2 adopted the mucin-secreting
phenotype. We believe this is not a limitation of our approach; instead,
it better reflects the in vivo emergence of BE cells under the conditions
of gastroesophageal reflux. Current thinking on BE pathogenesis sug-
gests that BE progression is due to clonal progression [54]. This in vitro
system may phenocopy this, as we observe a phenotypic shift in a
limited subset of cells. Under the selective pressure of gastroesophageal
reflux, these limited numbers of cells may have a growth advantage.
This is a hypothesis we are trying to test in future studies.
We also found it interesting that Muc5B was one of the mucins pro-
duced by these novel cell types because it is a mucin produced by
esophageal subepithelial gland cells [51,55]. We speculate that epithelial
stem cells may retain a capacity to give rise to alternative cell lineages,
particularly of nearby epithelial structures. There is some support for
this plasticity in the literature; hair follicle stem cells can contribute to
the epidermis in the setting of wound healing [51,55]. The long-term
effects of a chronic reflux injury may provoke these cells to adopt the
related epithelial lineage of subepithelial glandular cells in response.
One important question left unanswered is how Cox2 expression
leads to the observed morphologic and gene expression changes. It may
simply be the effects of prostaglandins on cell differentiation patterns,
Figure 10. Altered keratinocyte differentiation and induction of Muc17 in organotypically cultured Cox2-expressing keratinocytes. (A) Quan-
titative SYBR Green RT-PCR analysis of Muc17 mRNA expression in STR.M or STR.M.Cox2 cells cultured under normal two-dimensional
conditions or under three-dimensional organotypic conditions (OTSTR.M and OTSTR.M.Cox2). ΔC t values and statistical analysis were
calculated as before after duplicate PCRs for each sample, n = 4. *Significantly differs from all other cells, P < .01. (B) Negative immuno-
histochemical staining was observed for Muc17 in STR.M control cells but Muc17 staining localized to the mucin-containing cysts in
organotypic cultures of STR.M.Cox2 cells. (C) Filaggrin protein expression by immunohistochemistry in organotypic cultures of STR.M
and STR.M.Cox2 cells.
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mediated by their cell receptors. Alternatively, prostaglandin produc-
tion is associated with significant oxidative stress for the cells, which
can damage DNA and alter epigenetic configurations and gene expres-
sion patterns [56]. We favor the latter hypothesis and plan to investi-
gate this possibility in subsequent experiments.
Three-dimensional Culture Conditions Are a Critical
Component to In Vitro Modeling of BE
The importance of culture conditions on the behavior and dif-
ferentiation of human esophageal STR cells is well established by our
studies. Cell culture studies using primary esophageal keratinocytes have
explored the effects of various Barrett etiologic agents, including chronic
acid and bile acid treatment [57,58], bone morphogenetic protein 4
[59], retinoic acid [60,61], and the intestine-specific transcription factors
Cdx1 and Cdx2 [6,8,62]. Although these treatments did yield increased
expression of intestine-specific genes and some changes in cell mor-
phology, none succeeded at inducing a mucin-secreting cell type from
the keratinocytes. Early studies of gene expression patterns in the
STR.L.CatCLef and STR.M.Cox22 cells cultured under traditional
two-dimensional conditions were not encouraging. Only when the cells
were placed in conditions favoring cell differentiation did we observe the
significant changes, including greater intestinalization and, in the case of
Cox2, the emergence of polarized mucin-secreting cells.
The studies with the STR.M.Cox2 cells were particularly striking.
To our knowledge, the induction of polarized mucin-secreting cells
from human esophageal keratinocytes exceeds those of any previously
published study modeling BE in vitro. In addition, the presence of
Ki67+ cells associated with the large cyst suggests that a stem cell with
altered niche requirements is giving rise to the polarized secretory cells.
More work is needed to understand specifically what is happening with
these cells and how it might relate to the pathogenesis of BE. However,
based on these observations, all our future studies examining candidate
genes for contributions to BE will include culturing cells under organo-
typic conditions as a critical modeling approach.
Finally, it is not clear what it is about the organotypic culture condi-
tion that enables Cox2 or Wnt signals to provoke intestinalized gene
expression patterns. We suspect the close cell-cell contact provides a
permissive environment for these alterations. Moreover, with the cells
cultured densely, there will naturally be higher local levels of prosta-
glandins produced byCox2 activity. This alonemay be enough to induce
the observed changes. Alternatively, fibroblasts in the organotypic cul-
ture may respond to the prostaglandins by secreting other growth fac-
tors or cytokines that influence epithelial cell differentiation. We have
plans to test these possibilities in future experiments.
In conclusion, in vitro modeling of BE pathogenesis can be im-
proved by the inclusion of strategies to enhance Wnt signaling and
Cox2 activity and, most importantly, using three-dimensional organo-
typic culture conditions. Combining these strategies with others to
enhance goblet cell differentiation or the expression of Muc2 (such
as expressing the transcription factor Math1/HATH1) should be very
effective at improving the in vitro models. Once refined, these cell
culture–based models would serve as the rational basis to pursue the
development of appropriate transgenic mouse models and provide a
platform for testing novel diagnostic and therapeutic agents.
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Table W2. Screening Comparison of Gene Expression between OTSTR.L and OTSTR.L.CatCLef
Cells by Applied Systems Quantitative PCR Array.
Gene Name Fold Change EPC.CatCLef
β-catenin 93.65
KRT13 43.56
KRT4 19.44
KRT15 12.07
NHE2 7.32
KRT19 5.96
MUC4 5.23
KRT7 4.96
KRT10 4.45
NOTCH1 4.35
Cyclin D1 3.77
MUC5B 3.35
HES1 3.26
MUC1 2.68
Cox2 1.98
Villin 1.96
MUC16 1.95
KRT18 1.54
KRT1 1.51
KRT5 1.37
KRT8 1.34
MUC3A/3B 1.21
DRA 1.21
MUC12 1.21
MUC2 1.21
MUC5AC 1.21
MUC6 1.21
RETNLB 1.21
Sucrase Isomaltase 1.21
CDX2 1.21
KRT17 1.20
KRT16 1.16
p63 1.10
HATH1/ATOH1 1.07
Carbonic Anhydrase 1 1.01
Involucrin −1.03
KRT14 −1.14
KRT72 −1.15
KRT20 −1.26
MUC17 −1.47
CDX1 −2.22
MUC15 −2.96
MUC13 −6.06
FILAGGRIN −10.13
LORICRIN −37.22
Shaded data indicate genes that are two-fold different from controls.
Table W1. List of Applied Biosystems Assays Used.
Common Gene Name AB Gene Designation
β-catenin CTNNB1-Hs00355049_m1
Carbonic Anhydrase 1 CA1-Hs00266139_m1
CDX1 CDX1-Hs00156451_m1
CDX2 CDX2-Hs00230919_m1
Cox2 PTGS2-Hs01573471_m1
Cyclin D1 CCND1-Hs00277039_m1
DRA SLC26A3-Hs00230798_m1
FILAGGRIN FLG-Hs00863478_g1
HATH1/ATOH1 ATOH1-Hs00245453_s1
HES1 HES1-Hs00172878_m1
Involucrin IVL-Hs00846307_s1
KRT1 KRT1-Hs00196158_m1
KRT10 KRT10-Hs00166289_m1
KRT13 KRT13-Hs00999762_m1
KRT14 KRT14-Hs00265033_m1
KRT15 KRT15-Hs00267035_m1
KRT16 KRT16-Hs00373910_g1
KRT17 KRT17-Hs01588578_m1
KRT18 KRT18-Hs01653110_s1
KRT19 KRT19-Hs00761767_s1
KRT20 KRT20-Hs00300643_m1
KRT4 KRT4-Hs00361611_m1
KRT5 KRT5-Hs00361185_m1
KRT7 KRT7-Hs00559840_m1
KRT72 KRT72-Hs00603237_m1
KRT8 KRT8-Hs01670053_m1
LORICRIN LOR-Hs01894962_s1
MUC1 MUC1-Hs00159357_m1
MUC12 MUC12-Hs00419779_m1
MUC13 MUC13-Hs00217230_m1
MUC15 MUC15-Hs00377336_m1
MUC16 MUC16-Hs01065189_m1
MUC17 MUC17-Hs00959753_s1
MUC2 MUC2-Hs03005094_m1
MUC3A/3B MUC3B;MUC3A-Hs03649367_mH
MUC4 MUC4-Hs00366414_m1
MUC5AC MUC5AC-Hs01370716_m1
MUC5B MUC5B-Hs00861588_m1
MUC6 MUC6-Hs00401231_m1
NHE2 SLC9A2-Hs00268166_m1
NOTCH1 NOTCH1-Hs01062014_m1
p63 TP63-Hs00978340_m1
RETNLB RETNLB-Hs00395669_m1
Sucrase Isomaltase SI-Hs00356112_m1
Villin VIL1-Hs00200229_m1
Table W3. Screening Comparison of Gene Expression between OTSTR.M and OTSTR.M.Cox2
Cells by Applied Systems Quantitative PCR Array.
Gene Name Fold Change EPC.COX2
MUC17 28.48
Cox2 28.31
HATH1/ATOH1 13.43
MUC1 11.07
MUC5B 9.41
MUC3A/3B 5.49
KRT7 4.08
KRT19 2.05
β-catenin 1.81
Cyclin D1 1.55
Villin 1.37
DRA 1.37
MUC12 1.37
MUC2 1.37
MUC5AC 1.37
MUC6 1.37
RETNLB 1.37
Sucrase isomaltase 1.37
KRT8 1.32
HES1 1.29
p63 1.28
Involucrin 1.16
NOTCH1 1.15
KRT72 1.06
KRT16 −1.14
MUC16 −1.18
KRT18 −1.20
KRT15 −1.33
MUC13 −1.59
KRT17 −1.61
KRT20 −1.76
CDX1 −1.98
CDX2 −2.03
KRT4 −2.15
KRT5 −3.41
MUC15 −4.78
FILAGGRIN −4.80
Carbonic Anhydrase 1 −5.17
KRT14 −5.31
KRT13 −6.00
MUC4 −8.00
NHE2 −9.07
KRT10 −12.98
LORICRIN −13.23
KRT1 −15.38
Shaded data indicate genes that are two-fold different from controls.
